Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2016-12-15 Director's Dealing
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
FLAGGING I MEDISTIM ASA
Director's Dealing Classification · 95% confidence The document text explicitly states that 'Fond forvaltet av SKAGEN AS (SKAGEN Fondene) solgte i dag (15. desember 2016) 70 000 aksjer i Medistim ASA (MEDI)'. This describes a transaction involving the sale of shares by a fund manager. This directly corresponds to the definition of Director's Dealing (DIRS) or, more broadly, a notification of a change in significant share ownership. Since the transaction involves a fund manager selling shares, and the resulting holding (4.63%) is a significant stake, it fits the criteria for a Major Shareholding Notification (MRQ) or potentially DIRS if the fund manager is considered an insider/director, but MRQ is typically used for significant ownership changes reported by large shareholders. Given the context of reporting share transactions by a major holder, MRQ is the most precise fit among the options, as it reports crossing a threshold or a significant change in holding. If the transaction was by a director, DIRS would apply. Since it's a fund, MRQ (Major Shareholding Notification) is appropriate for reporting the change in ownership percentage.
2016-12-15 Norwegian
FLAGGEMELDING - MEDISTIM ASA
Director's Dealing Classification · 98% confidence The document is very short (314 characters) and reports a transaction involving shares by an entity named 'Stenshagen Invest AS' in 'Medistim ASA' on 14.12.2016. It explicitly states the number of shares sold and the resulting ownership percentage (3.47%). This content directly relates to insider or major shareholder transactions, which aligns perfectly with the definition of 'Director's Dealing' (DIRS) or potentially 'Major Shareholding Notification' (MRQ). Since the transaction involves a specific sale by an entity that remains a significant shareholder (3.47%), and given the context of regulatory reporting for share ownership changes, DIRS is the most appropriate fit for reporting personal/related party share transactions, although MRQ is also plausible if the change crossed a major threshold. Given the explicit reporting of a sale and resulting holding, DIRS (Director's Dealing/Insider Transaction) is the primary classification for reporting executive/related party trades.
2016-12-14 Norwegian
Medistim lanserer SonoQ
Regulatory Filings Classification · 100% confidence The document is a press release dated November 10, 2016, announcing the launch of a new product, 'SonoQ', by Medistim ASA. It details the product's features, the licensing agreement that enabled it, and the planned launch event (Coronary Congress in New Delhi). This type of announcement, focusing on a specific business event (product launch) rather than periodic financial results (ER, IR) or mandatory regulatory filings (10-K, DEF 14A), fits best under the general 'Regulatory Filings' (RNS) category, as it is an official company announcement that may be subject to disclosure rules, but does not match the more specific categories like Capital/Financing (CAP) or Management Change (MANG). Given the options, RNS serves as the appropriate catch-all for significant, non-financial operational news releases.
2016-11-10 Norwegian
Medistim launches the SonoQ
M&A Activity Classification · 99% confidence The document is a press release dated November 10th, 2016, announcing the launch of a new product, 'SonoQ', by Medistim ASA. It details the product, its market strategy (focusing on India), and includes quotes from the CEO. This type of announcement, which is not a formal financial report (like 10-K or IR), nor a management change (MANG), nor a dividend notice (DIV), nor a specific regulatory filing like DIRS or DVA, falls best under the general category of a Regulatory Filing (RNS) as it is a disclosure made under Norwegian law (§5-12) regarding a significant business event, often disseminated via regulatory news services. It is not an Earnings Release (ER) as it focuses on a product launch, not period results.
2016-11-10 English
3. kvartals rapport 2016 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report for Medistim ASA for the third quarter of 2016. It contains detailed financial statements, including income statements, balance sheet data, operational status by region, and management commentary on financial performance. It is not an announcement of a report, but the report itself, and it provides substantive financial data for a period shorter than a full fiscal year. Q3 2016
2016-10-19 Norwegian
3rd quarter financial report 2016 for Medistim ASA
Earnings Release Classification · 98% confidence The document provides detailed financial performance metrics, including Sales, Operating Profit (EBIT), Profit per share, Balance Sheet figures, and operational segment reviews, specifically for the '3rd quarter 2016' and year-to-date figures as of September 30, 2016. It contains comprehensive financial breakdowns, which is characteristic of a periodic financial report. Since it covers a period shorter than a full year (a quarter), it aligns best with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is very detailed, nor is it a full Annual Report (10-K). It is also not a mere announcement of a report (RPA) as the full content is present. Q3 2016
2016-10-19 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.